Cervical Cancer Diagnostics Market – Industry Analysis and Forecast (2020-2030) – By Diagnostic Test, By End User and By Region

The Business Research Company offers "Cervical Cancer Diagnostics Global Market Report 2020-30: Growth And Change" in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth, and highlights important trends and strategies that players in the market can adopt.

The global cervical cancer diagnostics market is expected to decline from $8.02 billion in 2019 to $7.23 billion in 2020 at a compound annual growth rate (CAGR) of -9.87%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, especially postponement of non-emergency procedures. The market is then expected to recover and reach $8.62 billion in 2023 at a CAGR of 6.04%.

Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3285

The cervical cancer diagnostics market consists of sales of cervical cancer diagnostic devices and related services by entities (organizations, sole traders and partnerships) that produce cervical cancer diagnostics devices. Cervical cancer is a type of cancer that occurs in cells of the cervix. These devices are used for the diagnosis of cervical cancer.

The rising adoption of cervical cancer diagnostic tests for the early detection of cervical cancer is expected to drive the market for cervical cancer diagnostics. Increasing awareness among women about cervical cancer along with the emphasis by worldwide cancer organizations and governments on early testing for detecting cervical cancer and preventing it contributes to the growth of the market. For instance, in August 2018, the United States Preventive Services Task Force has updated its screening guidelines for cervical cancer, which specifies that women between ages 21 to 29 should be screened with a Pap test every 3 years, women between ages 30 to 65 should be screened with any of three tests, namely high-risk HPV testing alone, Pap and high-risk HPV contesting for every 5 years and Pap test alone for every 3 years. The rising adoption of cervical cancer diagnostic tests and emphasis on early diagnosis propels the market.

Cervical Cancer Diagnostics Market Segmentation: -
By Diagnostic Test
Pap Smear Test
HPV Test
Colposcopy
Biopsy and Endocervical Curettage
Other Diagnostic Tests

By End User
Hospitals
Specialty Clinics
Cancer and Radiation Therapy Centres
Diagnostic Centres

Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/cervical-cancer-diagnostics-global-market-report-2020-30-growth-and-change

Few Points From Table Of Content
1. Executive Summary
2. Cervical Cancer Diagnostics Market Characteristics
3. Cervical Cancer Diagnostics Market Size And Growth
4. Cervical Cancer Diagnostics Market Segmentation
5. Cervical Cancer Diagnostics Market Regional And Country Analysis
.
.
.
25. Cervical Cancer Diagnostics Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Cervical Cancer Diagnostics Market
27. Cervical Cancer Diagnostics Market Trends And Strategies
28. Cervical Cancer Diagnostics Market Future Outlook and Potential Analysis
29. Appendix

The report covers the trends and market dynamics of the Cervical Cancer Diagnostics Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.

Request for a Sample Copy of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3285&type=smp

Some of the key players involved in the Cervical Cancer Diagnostics Market are Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hologic Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens Healthineers AG, Zilico, Guided Therapeutics.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/

About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.

This release was published on openPR.